Merck Loses Fosamax Trial Verdict
In a court room upset, Merck & Co. Inc. lost its second Fosamax lawsuit to a New York resident who claimed she suffered jaw injury due to the side effects of the osteoporosis drug. Reuters reports that the jury awarded the plaintiff $285,000 in the case, which was originally filed in 2008 in U.S District Court in Manhattan. The lawsuit alleged the plaintiff suffered delayed healing and a bone disease of the jaw following dental work because of the company’s